294 related articles for article (PubMed ID: 17317396)
1. Retinal pigment epithelial tear after intravitreal ranibizumab.
Bakri SJ; Kitzmann AS
Am J Ophthalmol; 2007 Mar; 143(3):505-7. PubMed ID: 17317396
[TBL] [Abstract][Full Text] [Related]
2. Retinal pigment epithelium tears following ranibizumab for exudative age-related macular degeneration.
Carvounis PE; Kopel AC; Benz MS
Am J Ophthalmol; 2007 Mar; 143(3):504-5. PubMed ID: 17317395
[TBL] [Abstract][Full Text] [Related]
3. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
[TBL] [Abstract][Full Text] [Related]
4. Retinal pigment epithelium tears following intravitreal ranibizumab therapy.
Kiss C; Michels S; Prager F; Geitzenauer W; Schmidt-Erfurth U
Acta Ophthalmol Scand; 2007 Dec; 85(8):902-3. PubMed ID: 17408387
[TBL] [Abstract][Full Text] [Related]
5. Retinal pigment epithelial tear after intravitreal bevacizumab injection.
Shah CP; Hsu J; Garg SJ; Fischer DH; Kaiser R
Am J Ophthalmol; 2006 Dec; 142(6):1070-2. PubMed ID: 17157598
[TBL] [Abstract][Full Text] [Related]
6. Tears of the retinal pigment epithelium: an old problem in a new era.
Chang LK; Sarraf D
Retina; 2007 Jun; 27(5):523-34. PubMed ID: 17558312
[TBL] [Abstract][Full Text] [Related]
7. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
[TBL] [Abstract][Full Text] [Related]
8. Retinal pigment epithelial tears in ranibizumab-treated eyes.
Smith BT; Kraus CL; Apte RS
Retina; 2009 Mar; 29(3):335-9. PubMed ID: 19174716
[TBL] [Abstract][Full Text] [Related]
9. A new grading system for retinal pigment epithelial tears.
Sarraf D; Reddy S; Chiang A; Yu F; Jain A
Retina; 2010; 30(7):1039-45. PubMed ID: 20458264
[TBL] [Abstract][Full Text] [Related]
10. Retinal pigment epithelial tear following intravitreal ranibizumab injections for neovascular age-related macular degeneration.
Lee GK; Lai TY; Chan WM; Lam DS
Graefes Arch Clin Exp Ophthalmol; 2007 Aug; 245(8):1225-7. PubMed ID: 17287977
[TBL] [Abstract][Full Text] [Related]
11. Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Gelisken F; Ziemssen F; Voelker M; Bartz-Schmidt KU
Acta Ophthalmol Scand; 2006 Dec; 84(6):833-4. PubMed ID: 17083554
[No Abstract] [Full Text] [Related]
12. Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
Spandau UH; Jonas JB
Am J Ophthalmol; 2006 Dec; 142(6):1068-70. PubMed ID: 17157597
[TBL] [Abstract][Full Text] [Related]
13. Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age-related macular degeneration.
Konstantinidis L; Ambresin A; Zografos L; Mantel I
Acta Ophthalmol; 2010 Nov; 88(7):736-41. PubMed ID: 19604160
[TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
[TBL] [Abstract][Full Text] [Related]
15. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.
Lalwani GA; Rosenfeld PJ; Fung AE; Dubovy SR; Michels S; Feuer W; Davis JL; Flynn HW; Esquiabro M
Am J Ophthalmol; 2009 Jul; 148(1):43-58.e1. PubMed ID: 19376495
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.
Nagiel A; Freund KB; Spaide RF; Munch IC; Larsen M; Sarraf D
Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309
[TBL] [Abstract][Full Text] [Related]
17. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Fung AE; Lalwani GA; Rosenfeld PJ; Dubovy SR; Michels S; Feuer WJ; Puliafito CA; Davis JL; Flynn HW; Esquiabro M
Am J Ophthalmol; 2007 Apr; 143(4):566-83. PubMed ID: 17386270
[TBL] [Abstract][Full Text] [Related]
18. Retinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachment.
Chan CK; Lin SG
Eur J Ophthalmol; 2007; 17(4):674-6. PubMed ID: 17671950
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal ranibizumab (Lucentis) for choroidal neovascularization associated with vitelliform macular dystrophy.
Querques G; Bocco MC; Soubrane G; Souied EH
Acta Ophthalmol; 2008 Sep; 86(6):694-5. PubMed ID: 18752521
[No Abstract] [Full Text] [Related]
20. Retinal pigment epithelial tear after intravitreal ranibizumab for subfoveal CNV secondary to AMD.
Apte RS
Int Ophthalmol; 2007 Feb; 27(1):59-61. PubMed ID: 17415530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
